New England Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $64.8K | Buy |
+54
| New | +$55.2K | 0.01% | 108 |
|
|
2024
Q1 | – | Sell |
-4,193
| Closed | -$2.44M | – | 104 |
|
|
2023
Q4 | $2.44M | Sell |
4,193
-517
| -11% | -$302K | 0.39% | 72 |
|
|
2023
Q3 | $2.53M | Sell |
4,710
-6,650
| -59% | -$3.43M | 0.42% | 67 |
|
|
2023
Q2 | $5.33M | Hold |
11,360
| – | – | 0.77% | 45 |
|
|
2023
Q1 | $3.9M | Sell |
11,360
-454
| -4% | -$153K | 0.58% | 55 |
|
|
2022
Q4 | $4.32M | Sell |
11,814
-9,100
| -44% | -$3.23M | 0.08% | 55 |
|
|
2022
Q3 | $6.76M | Sell |
20,914
-23,250
| -53% | -$7.37M | 0.12% | 34 |
|
|
2022
Q2 | $14.3M | Buy |
44,164
+750
| +2% | +$225K | 0.24% | 14 |
|
|
2022
Q1 | $12.4M | Buy |
43,414
+400
| +0.9% | +$103K | 0.2% | 15 |
|
|
2021
Q4 | $11.9M | Buy |
43,014
+3,650
| +9% | +$925K | 0.18% | 17 |
|
|
2021
Q3 | $9.1M | Buy |
39,364
+3,605
| +10% | +$890K | 0.16% | 18 |
|
|
2021
Q2 | $8.21M | Buy |
35,759
+1,050
| +3% | +$211K | 0.15% | 19 |
|
|
2021
Q1 | $6.48M | Sell |
34,709
-4,050
| -10% | -$792K | 0.13% | 26 |
|
|
2020
Q4 | $6.54M | Buy |
38,759
+900
| +2% | +$134K | 0.13% | 23 |
|
|
2020
Q3 | $5.6M | Sell |
37,859
-1,500
| -4% | -$232K | 0.13% | 27 |
|
|
2020
Q2 | $6.46M | Sell |
39,359
-3,470
| -8% | -$533K | 0.16% | 21 |
|
|
2020
Q1 | $5.94M | Buy |
42,829
+2,240
| +6% | +$308K | 0.14% | 23 |
|
|
2019
Q4 | $5.33M | Sell |
40,589
-600
| -1% | -$69.5K | 0.09% | 35 |
|
|
2019
Q3 | $4.61M | Hold |
41,189
| – | – | 0.09% | 38 |
|
|
2019
Q2 | $4.56M | Sell |
41,189
-364
| -0.9% | -$42.9K | 0.09% | 35 |
|
|
2019
Q1 | $5.39M | Sell |
41,553
-4,627
| -10% | -$563K | 0.1% | 32 |
|
|
2018
Q4 | $5.34M | Buy |
46,180
+1,600
| +4% | +$179K | 0.11% | 25 |
|
|
2018
Q3 | $4.78M | Buy |
44,580
+30
| +0.1% | +$3K | 0.08% | 32 |
|
|
2018
Q2 | $3.8M | Buy |
44,550
+4,750
| +12% | +$390K | 0.07% | 38 |
|
|
2018
Q1 | $3.08M | Buy |
39,800
+3,100
| +8% | +$250K | 0.06% | 45 |
|
|
2017
Q4 | $3.1M | Buy |
36,700
+200
| +0.5% | +$17K | 0.06% | 47 |
|
|
2017
Q3 | $3.12M | Buy |
36,500
+200
| +0.6% | +$16.4K | 0.07% | 45 |
|
|
2017
Q2 | $2.99M | Sell |
36,300
-800
| -2% | -$65.3K | 0.1% | 43 |
|
|
2017
Q1 | $3.12M | Buy |
37,100
+3,350
| +10% | +$268K | 0.05% | 48 |
|
|
2016
Q4 | $2.48M | Buy |
33,750
+4,750
| +16% | +$354K | 0.07% | 52 |
|
|
2016
Q3 | $2.33M | Buy |
29,000
+300
| +1% | +$24K | 0.09% | 55 |
|
|
2016
Q2 | $2.26M | Buy |
28,700
+200
| +0.7% | +$15.1K | 0.08% | 63 |
|
|
2016
Q1 | $2.05M | Sell |
28,500
-6,400
| -18% | -$484K | 0.06% | 63 |
|
|
2015
Q4 | $2.94M | Sell |
34,900
-900
| -3% | -$74.7K | 0.07% | 36 |
|
|
2015
Q3 | $3M | Buy |
35,800
+2,900
| +9% | +$245K | 0.08% | 55 |
|
|
2015
Q2 | $2.75M | Buy |
32,900
+800
| +2% | +$61K | 0.07% | 65 |
|
|
2015
Q1 | $2.33M | Buy |
32,100
+200
| +0.6% | +$14.2K | 0.06% | 71 |
|
|
2014
Q4 | $2.2M | Hold |
31,900
| – | – | 0.05% | 72 |
|
|
2014
Q3 | $2.07M | Sell |
31,900
-6,400
| -17% | -$405K | 0.05% | 84 |
|
|
2014
Q2 | $2.38M | Buy |
38,300
+300
| +0.8% | +$17.9K | 0.06% | 88 |
|
|
2014
Q1 | $2.24M | Sell |
38,000
-1,000
| -3% | -$55.8K | 0.06% | 84 |
|
|
2013
Q4 | $1.99M | Buy |
39,000
+1,300
| +3% | +$65.1K | 0.05% | 94 |
|
|
2013
Q3 | $1.9M | Buy |
37,700
+13,300
| +55% | +$696K | 0.06% | 92 |
|
|
2013
Q2 | $1.2M | Buy |
+24,400
| New | +$1.33M | 0.04% | 97 |
|
Other funds holding LLY
New England Asset Management's LLY Position: Q2 2026 in Review
New England Asset Management opened a new position in Eli Lilly (LLY) in Q2 2026: 54 shares worth $64.8K. The stake represents 0.01% of the portfolio and ranks #108 among its holdings. This is a return to the name: New England Asset Management previously reported a position in LLY as recently as Q4 2023.
New England Asset Management first reported a position in LLY in Q2 2013 and has held it in 44 quarters since. The position peaked at $14.3M in Q2 2022. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- New England Asset Management held 54 shares of Eli Lilly worth $64.8K as of Q2 2026.
- Eli Lilly was a new New England Asset Management position in Q2 2026.
- Eli Lilly made up 0.01% of New England Asset Management's portfolio in Q2 2026, its #108 holding.
- New England Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 44 quarters since.
- New England Asset Management's Eli Lilly position peaked at $14.3M in Q2 2022.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on New England Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.